| Rosuvastatin: switching treatment and clinical implications in primary care. |
| Author(s): Heiman F1, Ripellino C1, Colivicchi F2. |
| Affiliations(s): 1 IMS Health Information Solutions Italy Srl 2 Cardiology Division, S. Filippo Neri Hospital, ASL Roma 1, Rome, Italy. |
| Publication(s): |
| Document Type(s): Poster |
| Countries: Italy |
C:
Y: |
Cardiovascular disease, Metabolic Disorders
2016 |
|
L:
A: |
English
Clinical setting: Primary care, Database Study, Epidemiological study, Longitudinal study, Real World Data, Real World Evidence, Retrospective database analysis |
|
 |
| |
| |
| Pharmacoutilization in patients suffering from non-valvular atrial fibrillation. |
| Author(s): Cataldo N1, Ripellino C1, Di Virgilio R, De Solda S. |
| Affiliations(s): 1 IMS Health Information Solutions Italy, Srl, Milan, Italy. |
| Publication(s): ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria. |
| Document Type(s): Poster |
| Countries: Italy |
C:
Y: |
Cardiovascular disease
2016 |
|
L:
A: |
English
Database Study, Longitudinal study, Real World Data, Real World Evidence, Retrospective database analysis |
|
|
| |
| |
| Assessing the cost-effectiveness of transcatheter aortic valve implantation in operable patients with severe aortic stenosis in UK. |
| Author(s): Ramos M1, Lamotte M1, Chevalier P1, Goodall G2 |
| Affiliations(s): 1 QuintilesIMS, Zaventem, Belgium 2 Edwards Lifesciences, Nyon, Switzerland |
| Publication(s): 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
| Document Type(s): Abstract |
| Countries: UK |
C:
Y: |
Cardiovascular disease
2016 |
|
L:
A: |
English
Cost effectiveness, Cost utility |
|
|
| |
| |
| Rationale and design of a multi-center survey to evaluate productivity losses and indirect costs after cardiovascular events in Europe. |
| Author(s): Gerlier L1, Sidelnikov E2, Kutikova L2, Lamotte M1, Annemans L3 |
| Affiliations(s): 1 QuintilesIMS, Zaventem, Belgium 2 Amgen (Europe) GmbH, Zug, Switzerland 3 University of Ghent, Ghent, Belgium |
| Publication(s): 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
| Document Type(s): Abstract |
| Countries: Belgium, Czech, France, Germany, Hungary, Italy, Poland, Portugal, Romania, Spain, Switzerland, UK |
C:
Y: |
Cardiovascular disease
2016 |
|
L:
A: |
English
|
|
|
| |
| |
| Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting. |
| Author(s): Hasvold P1,2, Thuresson M3, Sundström J4, Hammar N5,6, Kjeldsen SE7,8, Johansson G9, Holme I10, Bodegård J11. |
| Affiliations(s): 1AstraZeneca, 151 85, Södertälje, Sweden. paal.hasvold@astrazeneca.com.
2Medical Faculty, University of Oslo, 0424, Oslo, Norway. paal.hasvold@astrazeneca.com.
3Statisticon AB, 753 22, Uppsala, Sweden.
4Department of Medical Sciences, Uppsala Clinical Research Center, Uppsala University, 751 05, Uppsala, Sweden.
5Institute of Environmental Medicine, Karolinska Institute, 171 77, Stockholm, Sweden.
6Medical Evidence and Observational Research, AZ R&D, Mölndal, Sweden.
7Medical Faculty, University of Oslo, 0424, Oslo, Norway.
8Department of Cardiology, Oslo University Hospital, Oslo, Norway.
9Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, 751 05, Uppsala, Sweden.
10Department of Sports Medicine, Norwegian School of Sport Sciences, PO Box 4014, Ulleval Stadion, 0806, Oslo, Norway.
11AstraZeneca, 151 85, Södertälje, Sweden. |
| Publication(s): Clin Drug Investig |
| Document Type(s): Article |
| Countries: Sweden |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease
2016 |
|
L:
A: |
English
Real World Evidence |
|
|
| |
| |
| Leveraging real-world evidence in disease management decision-making with a total cost of care (TCoC) estimator. American drug and health benefits. |
| Author(s): Nguyen TN, Trocio J, Kowal S, Ferrufino C; Munakata J,South D |
| Affiliations(s): |
| Publication(s): American Drug and Health Benefits. 2016 December; 9(9):475-484 |
| Document Type(s): Manuscript in preparation |
| Countries: USA |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease
2016 |
|
L:
A: |
English
Cost analysis |
|
|
| |
| |
| Minimizing burden of disease-related hospitalization among pulmonary arterial hypertension patients. |
| Author(s): Li S, Highland K, Cole M, Bilir P, Tsang Y, Graber-Naidich A, Kowal S, Drake W |
| Affiliations(s): |
| Publication(s): Academy of Managed Care Pharmacy (AMCP) Nexus 2016 Conference, 2016, October 3-6, National Harbor, Maryland |
| Document Type(s): Abstract |
| Countries: USA |
C:
Y: |
Cardiovascular disease
2016 |
|
L:
A: |
English
Budget impact, Cost analysis |
|
|
| |
| |
| Market uptake of direct oral anticoagulants (DOACS) in germany |
| Author(s): Batscheider A1, Greese B1, Dannemann S1, Gaba D2, Paulus G1, Stöcker P1, Greiner R1 |
| Affiliations(s): 1 QuintilesIMS, Munich, Germany 2 QuintilesIMS, Gurgaon, India |
| Publication(s): |
| Document Type(s): Poster |
| Countries: Germany, India |
C:
Y: |
Cardiovascular disease
2016 |
|
L:
A: |
English
Market impact |
|
|
| |
| |
| Estimating Canadian Heart Failure Prevalence Using Prescription Treatment Patterns |
| Author(s): Jobin Gervais K1, Zaour N1, Caron J2, Borrelli R2, Fischer A2 |
| Affiliations(s): 1 Novartis Pharmaceuticals Canada Inc., Dorval, QC, Canada 2 IMS Brogan, Mississauga, ON, Canada |
| Publication(s): |
| Document Type(s): Poster |
| Countries: Canada |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease
2016 |
|
L:
A: |
English
Retrospective cohort analysis |
|
|
| |
| |
| A Novel Method Using Prescription Treatment Patterns to Estimate Heart Failure Prevalence in Canada |
| Author(s): Jobin Gervais K1, Zaour N1, Caron J2, Borrelli R2, Fischer A2 |
| Affiliations(s): 1 Novartis Pharmaceuticals Canada Inc., Dorval, QC, Canada 2 IMS Brogan, Mississauga, ON, Canada |
| Publication(s): |
| Document Type(s): Poster |
| Countries: Canada |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease
2016 |
|
L:
A: |
English
Retrospective cohort analysis |
|
|
| |
| |
 2 of 43 
|
